X2 are provided by tumours in the hypotetraploid region, in the direction of a more favourable prognosis; and it may be that a finer pattern is emerging, with a worse-than-average prognosis for tumours in the hypertetraploid, hypodiploid and higher hyperdiploid regions (the latter corresponding to chromosome numbers of approximately 55). At least it seems worth while getting more data on the strength of the present results.
So far, only squamous cell carcinomas have been considered. It is of interest to consider adenocarcinoma of the cervix together with carcinoma of the corpus uteri (Table 3) . Of a series of 55 carcinomas of the corpus, treated by radiotherapy or by a combination of radiotherapy and surgery, 44 were in the hypodiploiddiploid-hyperdiploid region, and, of these, 10 (23 %) have recurred. The remaining 11 tumours were of high ploidy (mostly hypotetraploid), and no fewer than 10 of these have recurred. Of a small series of adenocarcinomas of the cervix, most of which have recurred following radiotherapy, the majority were in the hypotetraploid Table 3 DNA class and results of treatment of 55 carcinomas of the corpus and 15 adenocarcinomas of the cervix Carcinoma region. It appears, therefore, that the relationship between ploidy and prognosis is quite different for carcinoma of the corpus as compared with squamous cell carcinoma of the cervix, and adenocarcinoma of the cervix may follow the same pattern as carcinoma of the corpus in this respect. In a series of 48 adenoacanthomas of the cervix treated by radiotherapy, most of which have responded poorly to treatment, no relationship between ploidy and prognosis was discernible.
Thus, it may be concluded that although tumours show a wide and almost infinite variety of karyotypes, with chromosome numbers ranging from below diploid to above tetraploid, they tend to favour certain ploidy levels, and in squamous cell carcinomas of the cervix the ploidy level, as estimated by chromosome counts, DNA measurements, or less sensitively by nuclear size may be of prognostic significance. It is clear that, owing to the considerable variation in the chromosome number of different tumours, a large amount of data will be needed before the true relationship with prognosis can be evaluated. It remains to be seen whether detailed karyotype analyses will prove of greater value in predicting the response to treatment of a given tumour. In this country there are about 12 million women in the age range 30-65, the target population to be screened. There is some debate on the desired frequency of repeat tests. In the United States the test is usually repeated every year, while in Britain a frequency of up to five years issuggested, more for economnic reasons, I feel, than because of the welfare of the patient. A three-yearly repeat system seems a reasonable compromise, and thus about 4 million tests per year should cover the whole country. As most surveys have managed to get only a 50-60% response to advertising and direct communication, it is more realistic to assume 3 million smears as the expected yearly load. Assuming each technician can screen 5,000 smears per year, it would require a screener force of 600 with, in addition, roughly a tenth of that number of senior screeners and again of pathologists, to staff this service.
Collection of smears by Ayres spatular scrape using a vaginal speculum and taken by doctors would require something like 300 doctors and 300 nurses full time. At the rate of l5s per test this would cost about £2,250,000 per year. If an automated test requiring a simple posterior fornix aspirate by pipette would suffice, then nurses on their own could deal with twice the number of cases that a doctor/nurse combination would achieve collecting Ayres scrape smears, at less than a quarter of the cost. This has stimulated the search for techniques requiring only vaginal mucus as the test material. In this regard we have pursued two lines of investigation, that of enzyme assays and the use of the cell counter.
These results are presented on behalf of a team consisting of Dr H Ferreira and Dr N Jankey of the Chelsea Hospital for Women and ourselves from St Stephen's Hospital and the Royal Marsden Hospital. The projects are financed by the Medical Research Council and the Ministry of Health. The control of both groups of tests has been by exfoliative cytology examined in the three hospitals and by Dr I M P Dawson in the Westminister Hospital Group at the beginning of our survey.
Enzyme Tests
In 1950 Odell & Burt demonstrated an increased activity of the enzyme ,B-glucuronidase in vaginal mucus in cases of uterine cancer. Kasdon et al. (1953) devised a technique to estimate this enzyme and determined a level in pre-menopausal women where 80 % of the controls lay below and 90% of the cervical cancer cases lay above. Lawson & Watkins (1965) confirmed this, but with the less satisfactory figures of 40% false positives and 20% false negatives. They also carried out a comparative study between P-glucuronidase and oc-mannosidase, getting closely similar results.
In 1962 Bonham & Gibbs published their preliminary results using 6-phosphogluconate dehydrogenase (6-PGD), an enzyme of the We therefore started an investigation collecting posterior fornix mucus by bulb and pipette into pre-weighed ampoules with the aid of a small amount of distilled water. These were freeze dried, weighed, dispersed in water, spun and the enzyme activity determined on an autoanalyser using a modification of the method of Bonham & Gibbs. Results were expressed as units per gram dry weight of the sample. Assays above 80 units per gram have been taken as positive ( Table 2) . Thus of the cases of invasive cancer there is an almost 100% detection rate. In 2 of the cases of .adenocarcinoma which were missed (one each from cervix and corpus) the patients had been curetted thoroughly two weeks before and the concurrent cytology also did not show malignant cells.
Of the group of carcinoma-in-situ there is a persistent 50% failure of detection and this, though disappointing, may have an explanation. There is some evidence from the work of Chayen & Bitensky (1966, personal communication) who showed in their histochemical work that increased 6-PGD activity precedes the development of invasive characteristics in experimentally induced tumours of rat and mouse skin. Again, they stress that in published population surveys only about half the cases of carcinoma-in-situ of the cervix appear to result in frank invasive cancer. This suggests that there may be some correlation of enzyme inactivity with a good prognosis in the general group of carcinoma-in-situ. We are studying this matter further. figures to demonstrate a progressive increase in enzyme activity with age (Table 4 ). Table 5 shows there is no apparent difference within the menstrual cycle. In the next group (Table 6) we -see fewer raised enzyme titres in the antenatal period, but the titre rises in the postpartum period for about three months. There is a still higher proportion of false positive results after abortion. Table 7 demonstrates that trichomonas infection appears to be a cause of raised enzyme titre.
In Table 8 we have attempted to relate certain cellular components present in excess to enzyme test positivity. The most interesting feature here is the low rate in relation to cytolysis wherein many of the squame cells lose their cytoplasm, which may explain the lowered titres in pregnancy where cytolysis is prevalent. 
Cell Counter
In 1964 Ladinsky and her colleagues published an account of the use of a cell counter with a size distribution plotter. This machine operates on the principle that cells in an electrolytic solution are relatively nonconductive and thus impede an electric current in proportion to their volume. The counter has a tube possessing a small aperture across which there is placed an electric field. Cells in suspension in a beaker are drawn through this aperture and a pulse wave proportional to their volume is registered on the oscilloscope. By means of a size distribution plotter provided with upper and lower limit threshold settings a narrow range of cell volume can be selected and a count made of successive 50 c.p increases in volume. These are then plotted on paper. It was found that in normal cases a simple curve displayed diminishing numbers of cells as the size increased beyond 400 c. p whereas with a malignant case there is a secondary peak in the 500-700 c. p range suggesting to Ladinsky the presence of larger malignant cells. She used as a diluent Eagles medium containing 20% foetal calf serum and achieved a retrieval of 2-10 million cells.
In a series of 81 nonmalignant cases 72 gave a normal curve and 9 gave secondary peaks, a false positive rate of 11 %. Of the cervical dysplasias 5 out of 6, and of the carcinoma-in-situ group 11 out of 13 gave positive patterns. Of the 41 invasive carcinomas all gave a distinctly positive pattern. Thus there was an overall false negative rate of only 4%. No breakdown of cell clusters or cytoplasmic lysis was carried out.
We decided to investigate this instrument in conjunction with our enzyme survey. The washout solution in the preweighed enzyme tubes was altered from distilled water to saline and each sample was halved and studied by both techniques. The 0-25-0-5 ml half-sample for the counter was spun down and the supernatant fluid replaced by 15 ml of fresh particle free saline. This was shaken up and then strained through a 200 mesh sieve to remove mucoid or large cellular particles and the suspension put through the counter. Tables 10  and 11 show the results from our counts. It will be seen that our results do not agree with Ladinsky's. It is possible that the difference in sampling fluids may be relevant; Ladinsky used Eagles medium and we used saline. Attempts at improving our detection rate by cytoplasmic lysis using cetrimide has improved the quality of the secondary peaks but resulted in no overall increased accuracy.
Other Techniques Fluorescent microscopy: In 1952 Mellors et al. attempted to develop an automated technique using the fluorochrome berberine sulphate which stains the DNA yellow, but this and subsequent work with acridine orange staining the ribonucleic acid a flame orange in the cytoplasm of malignant cells have not so far provided a successful automated method.
Pattern recognition: Most researches are directed towards the development of a pattern recogtiition instrument and one of the first was the cytoanalyser built by the Airborne Instrument Laboratories of Miniola, NY, in 1965. It measured the size and depth of staining of the nucleus and the nucleocytoplasmic ratio. These are the most distinctive visual differences between benign and malignant cells. The instrument scans the cell smear and light passing through the field falls on a cathode of a photomultiplier tube which converts light intensity into a proportional electric current. This is recorded as pulse wave. This apparatus has not yet achieved sufficient accuracy. In a recent survey (Spencer & Bostrom 1962) 58% of 11,136 normal smears were rated as positive by the cytoanalyser; and at a score level of 36-6% true negatives there remained a false negative rate of 10-3 %. Many other pattern recognition instruments linked to computer recording analysis are being developed, such as the Fidac, Cell Scan, University are using a digital scanner to scan 35 mm films of cells in an assay of points with each point yielding a grey level number of 0-128 depending on the emulsion density in the film. The scan resolution can be varied from 4 lines each with 4 points to 256 lines each with 512 points. Such a line scan depicts the density of DNA throughout the nucleus and if these lines are arranged in parallel they will give an estimate of the irregularities of outline as well. Mendelsohn (D Rutovitz 1965, personal communication) in the University of Pennsylvania believes that morphology should play a secondary role and that the measurements to concentrate on are the integrating absorbency of the different portions of a chromosome or nucleus and that the pattern of variation of optical density rather than morphology can be used to identify DNA in the cell. For example, considering mean absorbence, separation of density modes, total absorbence, skewness of optical density distribution, nuclear area and cytoplasmic area, he is able to separate lymphocytes, monocytes, neutrophils and eosinophils by means of his instrument, which is given the code name CYDAC. This Cytophotometric Data Conversion System contains two independent microscope systems, one mechanical scanner based on a Nipkow disc in the image plane and the other a cathode ray tube flying spot scanner. The data are analysed by computer.
Finally I should like to quote the work of Kamentsky et al. (1965) from the IBM Watson Laboratory, Columbia University, NY, in their endeavour to establish the exact nucleocytoplasmic ratio as perhaps the most distinctive change in malignancy. He has devised a unique apparatuswhich measures the spectrophotometric properties of biological cells at the rate of 500 cells per second. He passes a cell stream through a grooved quartz slide which is roofed over by a quartz coverslip. Passing light from a low pressure mecury source across the channel, the light transmitted is then split by means of a quartz lens and dichroic mirror to image the 4000 to 6000 A component on to a photomultiplier while the shorter wave lengths are reflected at 90 degrees. The latter are then focused on to a solar blind photomultiplier (after passing through a quartz cell containing 1-4 diphenylbutadiniene dissolved in ethanol). This combination is effective in isolating the 2537 A line. As this wave length is near the absorption maximum of nucleic acid the two components together give an indication of the DNA/cell volume ratio.
Management of Carcinoma-in-situ of the Cervix
Carcinoma-in-situ became generally recognized in this country about fifteen years ago. The management of the condition can be considered in three phases. At first the diagnosis was made by histology on a punch biopsy of the cervix, taken because of intermenstrual or postmenopausal bleeding, or because of an unhealthy cervix which bled when it was touched or was found to be ulcerated or friable. Total abdominal hysterectomy was then the standard treatment. The condition was also discovered incidentally on routine histology following hysterectomy or amputation of the cervix. Then, if the cervix had been completely removed, there was nothing further to be done, but if a portion of it remained, it was difficult to know whether to leave it or to do a hysterectomy.
In the second phase, cytology was used to detect the lesion in symptom-free patients and the number of cases greatly increased. The cervix usually appeared normal or there was a benignlooking erosion. An adequate biopsy was required for diagnosis and to exclude invasion; and because the lesion was most often found in the endocervical canal, a cone biopsy became the rule. Total hysterectomy was still the usual treatment. Some gynaecologists, mindful of the occasional vault occurrence, also removed a small cuff of vagina. This meant tying the uterine arteries near the side wall of the pelvis and dissecting out the ureter from its tunnel in the parametrium. There is, of course, no need to remove regional lymph nodes or ovaries. The adequacy of operation was Young women were often treated conservatively if they wished to have more children. This entailed relying on the cone biopsy or cauterizing the remaining epithelium in addition. In conservatively treated cases, there was a possiblity of the lesion still being present and recurring in the cervix and, therefore, follow-up cervical smears took on an even greater importance.
In the third and final phase some gynaecologists adopted a more conservative attitude to treatment generally, arguing that if local removal or cauterization was adequate for younger pateints, it should also be applicable to others. Table 1 summarizes three schemes of management.
Our experience at the Chelsea Hospital for Women illustrates these points. The annual incidence of carcinoma-in-situ is shown in Table  2 .Routine cervical smears were not used until 1960 and in the previous ten years only 44 cases were diagnosed, an average of less than 5 cases each year. In the six years from 1960 to 1965, however, 115 cases were diagnosed, two-thirds as the result of a positive smear, giving an average of 19 cases each year. In the ten years before 1960, 20 cases were diagnosed on biopsy because the surgeon suspected a malignantlesion ofthe cervix, 20 cases were diagnosed by histology after operation and in only 4 was biopsy performed because of a positive smear (Table 3 ). Most of these cases were treated by total hysterectomy and only 3-were treated conservatively (Table 4) .
From 1960 the management at Chelsea began to change; most cases were detected by cervical smear and the diagnosis was established in every one by a good-sized biopsy. This was usually a cone biopsy to include the endocervical canal and
